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Bacillus subtilis has a constitutive system for the uptake of a-keto-,8-methyl-
valerate, a-ketoisovalerate, and (probably) a-ketoisocaproate. A mutation,
kauAl, which blocks the uptake of a-keto-,B-methylvalerate and a-ketoisovaler-
ate, is located between metB and citK on the B. subtilis chromosome.
Bacillus subtilis strain CU906 is a derivative
of strain 168I- which carries an ilvB deletion
mutation and a leuB mutation and, therefore,
requires the branched-chain amino acids iso-
leucine, valine, and leucine. It can also satisfy
these growth requirements with the corre-
sponding a-keto acids: a-keto-,3methylvalerate
78 (18/1))
87 (9,68)
metB5
21 (Us4 L
_ 19 (S.? /o)
kauAl cItKl
FIG. 1. Genetic map of the metB-citK region of the
chromosome ofB. subtilis showing the position ofthe
kauAl marker. A three-point cross was carried out
between two strains isogenic for an ilvB deletion
(necessary for scoring kauAl, which is silent in the
absence of a requirement for isoleucine or valine).
The donor in the phage PBS1 transduction was
strain CU450 (trpC2, ilvBAl1, citKl). The recipient
was strain CU968 (trpC2, ilvBAl, metB5, kauAl).
Selection was for Met+or for Kau+. Of81 Met+ trans-
ductants tested, none were Kau and CitK- all other
recombinant classes were found. This indicates the
order of genes shown. Data from a two-point cross
linking citKl and kauAl are included in the figure.
Map distances are given as phage PBS1 transduction
units, calculated as (100 - percentage of co-transfer
of the two markers). The arrows point from the se-
lected to the unselected markers. The numbers in
parentheses indicate the actual number of co-trans-
ductants found among the total colonies tested in
each cross. Genetic techniques used were previously
reported (4).
(KMV), a-ketoisovalerate (KIV), and a-keto-
isocaproate (KIC). We mutagenized strain
CU906 with N-methyl-N'-nitro-N-nitrosoguan-
idine and imposed a penicillin selection (4) for
mutants unable to use the a-keto acids for
growth. A mutant strain, CU961, was isolated
that could not use 0.3 mM DL-KMV or KIV to
satisfy its isoleucine and valine requirements,
although it could still use 0.3 mM KIC to satisfy
its leucine auxotrophy. We have named the
mutation responsible for this phenotype kauAl;
its genetic map position is in the metB-citK re-
TABLE 1. Rate ofKIV uptake in the presence of
various inhibitorsa
Rate of uptake (%)
Inhibitorb 5 AM inhibi- 100 A±M inhibi-
tor concn tor concn
L,Leucine - 53
L-Isoleucine - 63
L-Valine - 74
KIC 31 3.7
DL-KMV 48 2.5
KIV 60d -
Pyruvate - 96
a-Ketoglutarate - 85
a-Ketobutyrate - 53
a The rate of KIV uptake is given as a percentage
of the rate ofuptake seen in this experiment with no
inhibitor added. The [KIVI was 1.6 ,uM and the rate
of uptake with no inhibitor present was observed to
be 1.7 nmol/min per mg of protein. Uptake rates
were measured as described in Fig. 3A.
b Inhibitors were adjusted to pH 7 before use.
c A dash indicates that the assay was not per-
formed.
d In this assay, enough unlabeled KIV was added
to bring the final [KIV] to 6.6 uM. This point may
thus be directly compared to the other values in this
column.
gion (Fig. 1), unlinked to the ilvB and leuB mu-
tations. We have isolated two other mutants
with similar defects; their mutations lie very
close to kauAl and are probably in the same
gene. The kauA mutations are silent in strains
that do not carry ilv mutations; i.e., such
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strains are prototrophic. The aminotransferase
activities of the mutant strain CU961 for iso-
leucine and valine, measured in both the for-
ward and reverse directions with a-ketoglu-
tarate and L-glutamate by the method ofTaylor
and Jenkins (3), did not differ significantly
from those of the parent strain CU906.
Strain CU992 (trpC2 kauAl) and the iso-
genic strain CU120 (trpC2) were tested for up-
take of KIV; the results are shown in Fig. 2.
The uptake of KIV was virtually absent in the
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strain carrying the kauAl marker, whereas es-
sentially linear uptake was observed for at
least 5 min in the Kau+ strain (Fig. 2, inset).
Since similar activity was seen whether or not
the glucose-salts growth medium contained
KIV, the uptake system for KIV appears to
be constitutive.
Using strain CU120, the kinetics of the up-
take system for KIV was studied. The results
of a substrate saturation experiment are shown
in Fig. 3A; a double-reciprocal plot of these
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FIG. 2. Uptake ofKIV versus time with strains CU992 (trpC2, kauAl) and CU120 (trpC2). Symbols: 0,
CU120 grown in minimal medium; 0, CU120 grown with KIV; *, CU992 grown in minimal medium; U,
CU992 grown with KIV. For each time point, two separate determinations were made; the line is drawn
through their mean. Cells were grown for 5 h at 37 C with aeration in 70 ml of medium containing (in
micrograms per milliliter): L-glutamate, 100; L-tryptophan, 50; D-glucose, 5,000; and, where applicable, KIV,
40; in BS. BS is a salts solution containing (in milligrams per milliliter): (NH4)2SO4, 2; K2HPO4, 14;
KH2PO4, 6; sodium citrate 2H20, 1; and MgSO4 * 7H20, 0.2. After harvesting, cells were washed twice with
BS, resuspended in about 5 ml ofBS, and kept on ice prior to their immediate use. Samples were removed,
and total cell protein (usually about 300 pg/ml) was estimated by the method ofLowry et al. (1), using bovine
serum albumin as standard. For the uptake assay, 0.2 ml ofcell suspension was equilibrated in 0.4 ml of0.2%
D-glucose in BS at 30 C for 5 min. Then, 5 p,l of [14C]KIV (49 p.Cilpmol; 0.2 pmollml) (prepared by a
modification of the method ofMeister [2] and adjusted to pH 7) was added and the tube was reincubated at
30 C. The final concentration of KIV in this assay was thus 1.7 pM. Samples of 100 p1 were removed at
appropriate times and filtered through 0.45-p,m pore size nitrocellulose filters (Matheson-Higgins Co.)
presoaked with 0.15 MNaCl and immediately washed with 8 ml of0.15 MNaCl. Filters were dried for 12 min
at 165 C and counted in a fluid containing 4.02 g of2,5-diphenyloxazole (PPO) and 0.10 g of 1,4-bis[2]-(4-
methyl-5-phenyloxazolyl)benzene (dimethyl-POPOP) per liter of toluene in a Beckman LS-230 scintillation
counter for 10 min. Background counts for the assay were determined by using tubes equilibrated at 30 C for 5
min and then chilled to 0 C; the assay was run as above but at 0 C. These counts were subtracted from the
experimental values obtained at 30 C to calculate the counts taken up by the cells after various elapsed times.
The number of moles of KIV taken up was estimated from these data by counting a known quantity of['4C]KIV solution absorbed into filters, which were subsequently dried and counted as above. Data for the
inset were obtained in a separate experiment from that shown in the figure.
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FIG. 3. (A) Rate ofKIV uptake versus external concentration ofKIV. The uptake assay was performed as
described in Fig. 2. Cells were grown without KIV. Unlabeled KIV (adjusted to pH 7) was added to assay
tubes to increase the external concentration ofKIV; the quantity of['4C]KIVpresent was the same as described
in Fig. 2. The rate of uptake was calculated by measuring KIV uptake in triplicate assay samples at 1 and 3
min elapsed time and finding the KIV uptake per minute. (B) Double-reciprocal plot of the data presented in
(A).
data appears in Fig. 3B. The measured K,,, for
KIV in this experiment was 14 ,uM; the V,,,(,,.
of uptake was 9.6 nmol/min per mg of protein.
To investigate the specificity of the KIV up-
take system, the rate of KIV uptake was meas-
ured for strain CU120, with various potential
inhibitors present at either 5 or 100 ,uM in the
usual uptake assay (Table 1). Strong inhibition
was seen with KMV and KIC. A lower but
significant amount of inhibition occurred with
the branched-chain amino acids. It was not due
to contamination of the amino acid solutions by
a-keto acids.
We examined the inhibition of KIV uptake
by KMV and KIC in strain CU120 (Fig. 4). The
inhibition due to KMV and to KIC was found
to be competitive; the measured K, values for
uptake were 3.5 and 4.1 u.M for racemic KMV
and for KIC, respectively.
The system affected by the kauAl mutation
appears to function in the uptake of the three
branched-chain a-keto acids (KIV, KMV, and
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FIG. 4. Double-reciprocal plots of rate ofKIV uptake versus external concentration ofKIV in the absence
and presence of2O MM DL-KMV. This experiment was performed as described in Fig. 3A. For each data point,
the average oftwo separate determinations is shown. In this experiment, the K,) for KIV was 9.7 uM and the
Vmar for uptake was 15 nmol/min per mg ofprotein. An analogous experiment was performed with 20 pM
KIC, and similar results were obtained. In this latter experiment, the K,m forKIV was 20 pM and the V,,,l was
24 nmol/min per mg ofprotein.
KIC) in B. subtilis. Since the mutant strain,
CU961, originally isolated from the penicillin
selection was able to utilize externally supplied
KIC, there must be an alternate system for the
uptake of KIC in B. subtilis that does not func-
tion in the uptake of KIV or KMV.
We wish to thank J. Calvo for helpful discussions and
the generous gift of ('4C]valine, R. Hallberg for the use of
his scintillation counter, and J. Ludford for the details of
the uptake assay.
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